Dr. Maximilian Lasson

About Dr. Maximilian Lasson

Max focuses on cross-border private M&A transactions for both corporate clients and financial sponsors.

Max has a strong track record in the Industrials sector, with a particular focus on chemicals and aerospace. His key areas of expertise include complex, multinational carve-out transactions and joint ventures. Max is also experienced in post-M&A litigation. 

He speaks German, English and French.

Recent work

• Airbus Defence and Space GmbH on the purchase of Infodas;
• Röhm Holding GmbH on the purchase of SABIC's worldwide polycarbonate business; 
• LANXESS on the carve-out acquisition of the Microbial Control Business of International Flavors & Fragrances (IFF);
• LANXESS Deutschland GmbH on the carve-out and divestiture of its worldwide organic leather chemicals business to TFL Ledertechnik GmbH; 
• Providence Equity Partners VI International LP on the fund-to-fund transfer of HSE24 group to Providence Equity Partners (Judith) LP; 
• Advent International Corporation on the carve-out acquisition of the (poly-)methacrylate business of Evonik Industries AG;
• LANXESS Deutschland GmbH on the divestiture of its 50 percent stake in ARLANXEO Holding B.V. to Aramco;
• Evonik Industries AG on various disputes with the general contractor in connection with the construction of the coal-fired power plant Walsum 10;
• Mianello Limited on the acquisition of LLC Media-Saturn-Russland from Media-Saturn-Holding GmbH and the parallel disposal of a stake in M.video to Media-Saturn-Holding GmbH;
• HOCHTIEF Aktiengesellschaft on the creation of a joint venture with ACS and Atlantia in connection with the public takeover of Abertis;
• RELX Deutschland GmbH on the acquisition of PatentSight Group from its founders;
• Knauf International GmbH on the acquisition of the suspended ceilings business in EMEA and APAC from Armstrong World Industries;
• DEUTZ Aktiengesellschaft on the acquisition of Torqeedo Group from Stephan Schambach and others;
• LANXESS Deutschland GmbH on the carve-out of its worldwide rubber business and the creation of the ARLANXEO joint venture with Aramco;
• Airbus Defence and Space GmbH and Airbus DS SAS on the carve-out of their defence electronics business and the divestiture of that business together with the Optronics business to Kohlberg Kravis Roberts & Co;
• Cinven Capital Management (V) GP Ltd and Canada Pension Plan Investment Board on the acquisition of Hotelbeds Group from TUI AG;
• Airbus SAS on its joint venture Elbe Flugzeugwerke GmbH with Singapore Technologies Aerospace Ltd; and
• Ergon Capital Partners II SA on the divestiture of PharmaZell Group.